<html>
<head>PUBMED IDs for XLPD</head>
<body bgcolor='#C5F0F2'><h1>XLPD</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11513145/'>2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes.</a> August 22  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12213321/'>CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function.</a> September 6  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12704588/'>Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.</a> April 22  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/23613254/'>X-linked reticulate pigmentary disorder with systemic manifestations: a new family and review of the literature.</a> April 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/27019227/'>DNA polymerase-Î± regulates the activation of type I interferons through cytosolic RNA:DNA synthesis.</a> September 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28407217/'>Evolution of the skin manifestations of X-linked Pigmentary Reticulate Disorder.</a> April 14  2017<br></body></html>
